Healthequity Free Cash Flow Trend from 2010 to 2022

HQY
 Stock
  

USD 57.67  3.72  6.06%   

Healthequity Free Cash Flow yearly trend continues to be fairly stable with very little volatility. Free Cash Flow will likely drop to about 65.6 M in 2022. During the period from 2010 to 2022, Healthequity Free Cash Flow regression line of anual values had slope of 8,162,580 and arithmetic mean of  45,100,187. Healthequity Direct Expenses is fairly stable at the moment as compared to the past year. Healthequity reported Direct Expenses of 332.85 Million in 2021. Cost of Revenue is likely to rise to about 359.1 M in 2022, whereas Consolidated Income is likely to drop (45.5 M) in 2022.
  
Refresh
Check Healthequity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Healthequity main balance sheet or income statement drivers, such as Direct Expenses of 359.1 M, Cost of Revenue of 359.1 M or Gross Profit of 457.2 M, as well as many exotic indicators such as Interest Coverage of 1.19, Long Term Debt to Equity of 0.71 or PPandE Turnover of 35.09. Healthequity financial statements analysis is a perfect complement when working with Healthequity Valuation or Volatility modules. It can also supplement various Healthequity Technical models. Please check the analysis of Healthequity Correlation against competitors.

Healthequity Quarterly Free Cash Flow

(7.71 Million)

Share

Healthequity Free Cash Flow Breakdown

Showing smoothed Free Cash Flow of Healthequity with missing and latest data points interpolated. Free Cash Flow is a measure of financial performance calculated as Net Cash Flow from Operations minus Capital Expenditure.Healthequity's Free Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Healthequity's overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow10 Years Trend
Increasing
Slightly volatile
 Free Cash Flow 
Share
      Timeline 

Healthequity Free Cash Flow Regression Statistics

Arithmetic Mean 45,100,187
Geometric Mean 28,751,084
Coefficient Of Variation 85.04
Mean Deviation 33,681,125
Median 32,916,000
Standard Deviation 38,352,741
Range 110,112,000
R-Value 0.83
R-Squared 0.69
Significance 0.00046157
Slope 8,162,580

Healthequity Free Cash Flow History

201312.6 M
20146.9 M
201517.3 M
201632.9 M
201765.9 M
201899.6 M
201972.1 M
2020117 M
202169.4 M
202265.6 M

Other Fundumenentals of Healthequity

Healthequity Free Cash Flow component correlations

About Healthequity Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Healthequity income statement, its balance sheet, and the statement of cash flows. Healthequity investors use historical funamental indicators, such as Healthequity's Free Cash Flow, to determine how well the company is positioned to perform in the future. Although Healthequity investors may use each financial statement separately, they are all related. The changes in Healthequity's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Healthequity's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Healthequity Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Healthequity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Free Cash Flow per Share 0.83  0.91 
Free Cash Flow69.4 M65.6 M
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company was incorporated in 2002 and is headquartered in Draper, Utah. Healthequity operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3688 people.

Healthequity Investors Sentiment

The influence of Healthequity's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Healthequity. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Healthequity Implied Volatility

    
  37.77  
Healthequity's implied volatility exposes the market's sentiment of Healthequity stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Healthequity's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Healthequity stock will not fluctuate a lot when Healthequity's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Healthequity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Healthequity's short interest history, or implied volatility extrapolated from Healthequity options trading.

Current Sentiment - HQY

Healthequity Investor Sentiment

Greater number of Macroaxis users are currently bullish on Healthequity. What is your judgment towards investing in Healthequity? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Healthequity using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check the analysis of Healthequity Correlation against competitors. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.2 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.